Akebia Therapeutics Appoints Myles Wolf, M.D., M.M.Sc., Chief of Nephrology and Professor at Duke University School of Medicine, to Board of Directors by Seini Moimoi | Apr 7, 2020 | Portfolio News
Kala Pharmaceuticals Announces Exercise of Underwriters’ Option to Purchase Additional Shares by Seini Moimoi | Apr 3, 2020 | Portfolio News
Encore Dermatology Inc. Acquires SERNIVO®, TRIANEX® and PROMISEB®. by Seini Moimoi | Apr 2, 2020 | Portfolio News
Aptinyx Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update by Seini Moimoi | Mar 30, 2020 | Portfolio News
Inzomelid completes Phase I studies and shows positive results in the treatment of Cryopyrin-Associated Periodic Syndrome (CAPS) by Seini Moimoi | Mar 26, 2020 | Portfolio News
